Ensuring timely antibody supply during the COVID-19 pandemic - contact us for solutions

Goat Anti-Hamster IgG(H+L)-FITC

Cat. No.:
6060-02
Goat Anti-Hamster IgG(H+L)-FITC antibody for use in western blot and other fluorescent assays.
$90.00
Size Price (USD) Quantity
1.0 mg $90.00
More Information
Isotype Goat IgG
Isotype Control Goat IgG-FITC
Specificity Reacts with the heavy and light chains of hamster IgG; may only react with Syrian hamster IgG
Source Pooled antisera from goats hyperimmunized with hamster IgG
Cross Adsorption None; may react with immunoglobulins from other species and the light chains of other hamster immunoglobulins
Purification Method Affinity chromatography on hamster IgG covalently linked to agarose
Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Polyclonal
Concentration 1.0 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Applications Quality tested applications for relevant formats include -
ELISA 1-5
FLISA

Other referenced applications for relevant formats include -
Western Blot 6-8
Separation 9
RRID Number AB_2796128

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J Exp Med. 1996;184:1999-2006. (ELISA)
  2. 2. Matsuo K, Isogai E, Araki Y. Control of immunologically crossreactive leptospiral infection by administration of lipopolysaccharides from a nonpathogenic strain of Leptospira biflexa. Microbiol Immunol. 2000;44:887-90. (ELISA)
  3. 3. Ploquin A, Szécsi J, Mathieu C, Guillaume V, Barateau V, Ong KC, et al. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines. J Infect Dis. 2013;207:469-78. (ELISA)
  4. 4. Corral MJ, Serrano DR, Moreno I, Torrado JJ, Domínguez M, Alunda JM. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis. J Antimicrob Chemother. 2014;69:3268-74. (ELISA)
  5. 5. Das A, Ali N. Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection. PLoS Negl Trop Dis. 2014;8(8):e3091. (ELISA)
  6. 6. Yang C, Shi W, Basu L, Murti A, Constantinescu SN, Blatt L, et al. Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J Biol Chem. 1996;271:8057-61. (WB)
  7. 7. Lawlor KE, Smith SD, van Nieuwenhuijze A, Huang DC, Wicks IP. Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritis. J Leukoc Biol. 2011;90:819-29. (WB)
  8. 8. Peperzak V, Vikström I, Walker J, Glaser SP, LePage M, Coquery CM, et al. Mcl-1 is essential for the survival of plasma cells. Nat Immunol. 2013;14:290-7. (WB)
  9. 9. Linnemeyer PA, Pollack SB. Stage-specific expression of activation antigens on NK cells at uterine implantation sites in mice. J Immunol. 1994;153:1478-86. (Sep)
See All References